Clinical Trial: Adaptive Therapy for Post-Second-Line Advanced Breast Cancer
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: HER2-negative Metastatic Breast Cancer
Study Type: INTERVENTIONAL
Official Title: A Phase II Study of the Efficacy and Safety of Adaptive Therapy for Metastatic Refractory Breast Cancer
Brief Summary:
The primary objective of this study is to explore the efficacy and safety of adaptive therapy in the treatment of post-second-line metastatic breast cancer.
Read more